BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24159776)

  • 1. [Chronic prostatitis, benign prostatic hyperplasia and immunity: the disorders and correction].
    Konoplia AI; Teodorovich OV; Shatokhin MN; Gavriliuk VP; Mavrin MIu
    Urologiia; 2013; (4):99-103. PubMed ID: 24159776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunocorrecting therapy of chronic bacterial prostatitis].
    Novikov AI; Zaezzhalkin VV; Kucherov VA; Frolov SIu
    Urologiia; 2010; (4):44, 46-8. PubMed ID: 20973134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis].
    Seregin SP; Bratchikov OI; Konoplia AI; Shestakov SG; Dolzhenkov SD; Novikov AV; Shatokhin MN; Kotov AV
    Urologiia; 2002; (4):14-6. PubMed ID: 12357892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correction of local immunometabolic disturbances combined with chronic prostatitis in prostatic adenoma].
    Teodorovich OV; Shatokhin MN; Mal'tsov VN; Konoplia AI; Loktiononv AL; Krasnov AV
    Urologiia; 2010; (5):22-6. PubMed ID: 21254636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitaprost forte efficacy in patients with prostatic adenoma].
    Tkachuk VN; Tkachuk IN
    Urologiia; 2008; (4):34-7. PubMed ID: 19058362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of benign prostate hyperplasia with prostatitis].
    Long Z; He L; Zhong K; Zhang Y; Yue D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):381-5. PubMed ID: 20448364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatitis and prostatodynia: their relationship to benign prostatic hypertrophy.
    Drach GW
    Urol Clin North Am; 1980 Feb; 7(1):79-88. PubMed ID: 6154991
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience in the use of prostatilen in urology].
    Al'-Shukri SKh; Bobkov IuA; Gorbachev AG; Kuz'min IV; Tkachuk VN
    Urologiia; 2003; (6):32-6. PubMed ID: 14708243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of chronic bacterial prostatitis on changes in concentration and free and total prostatic specific antigen in the serum and urine from patients with benign prostatic hyperplasia and prostatic cancer].
    Mazo EB; Grigor'ev ME; Stepenskiĭ AB
    Urologiia; 2001; (5):3-7. PubMed ID: 11641977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of bacterial prostatitis in benign prostatic hyperplasia.
    Mohanty NK; Jolly BB
    Indian J Pathol Microbiol; 1996 Apr; 39(2):111-4. PubMed ID: 9401238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostagut forte treatment of patients with prostatic adenoma with comorbid chronic prostatitis].
    Avdoshin VP; Pul'bere SA
    Urologiia; 2012; (2):44, 46-7. PubMed ID: 22876633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign prostate hyperplasia with chronic prostatitis: an update].
    Ma Y; Zhang WL
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
    Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
    Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
    Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
    Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
    Pawlicki B; Zieliński H; Dabrowski M
    Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the medical treatment reduces the rate of surgical treatment in suspected cases of chronic prostatitis before prostatectomy?
    Mustafa G; Ilhan G; Necip P; Kürsat C; Kerem T; Kadir C; Hüseyin Ö
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(1):119-22. PubMed ID: 23329532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of vitaprost forte in patients with prostatic adenoma].
    Miller AM; Iaroshenko VP; Soroka PV; Stakhnev EIu
    Urologiia; 2008; (5):50, 52-4. PubMed ID: 19069497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimal treatment of benign prostatic hyperplasia (BPH) with comorbid chronic prostatitis (category IIIA)].
    Golubchikov VA; Sitnikov NV; Kochetov AG; Perekhodov SN; Sidorov OV; Roiuk RV; Nagoprniuk VN; Tsibizov DN
    Urologiia; 2005; (4):9-12. PubMed ID: 16158737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.